{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T03:58:04Z","timestamp":1762747084509,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clml.2022.08.010","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T02:31:17Z","timestamp":1661221877000},"page":"e1075-e1083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5258-2140","authenticated-orcid":false,"given":"Chantiya","family":"Chanswangphuwana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantana","family":"Polprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weerapat","family":"Owattanapanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smith","family":"Kungwankiattichai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2381-9292","authenticated-orcid":false,"given":"Adisak","family":"Tantiworawit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanawat","family":"Rattanathammethee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1451-7636","authenticated-orcid":false,"given":"Wasithep","family":"Limvorapitak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supawee","family":"Saengboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimjai","family":"Niparuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teeraya","family":"Puavilai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-9479","authenticated-orcid":false,"given":"Jakrawadee","family":"Julamanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirun","family":"Saelue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinadol","family":"Wanitpongpun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chajchawan","family":"Nakhakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kannadit","family":"Prayongratana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantrapa","family":"Sriswasdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2022.08.010_bib0001","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0145-2126(95)00049-T","article-title":"Secondary acute myeloid leukemia","volume":"19","author":"Bennett","year":"1995","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2022.08.010_bib0002","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00277-019-03606-0","article-title":"The leukemia strikes back: a review of pathogenesis and treatment of secondary AML","volume":"98","author":"Cheung","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2022.08.010_bib0003","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1200\/JCO.2014.60.0890","article-title":"Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study","volume":"33","author":"Granfeldt \u00d8stg\u00e5rd","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2022.08.010_bib0004","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.23908","article-title":"Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry","volume":"90","author":"Huleg\u00e5rdh","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2022.08.010_bib0005","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/bloodadvances.2021005335","article-title":"Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study","volume":"6","author":"Mart\u00ednez-Cuadr\u00f3n","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2022.08.010_bib0006","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.21873\/anticanres.14269","article-title":"Characterization and prognosis of secondary acute myeloid leukemia in an Asian population: AML with antecedent hematological disease confers worst outcomes, irrespective of cytogenetic risk","volume":"40","author":"Kim","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clml.2022.08.010_bib0007","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.08.010_bib0008","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/genes11080845","article-title":"AML with myelodysplasia-related changes: development, challenges, and treatment advances","volume":"11","author":"Koenig","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.clml.2022.08.010_bib0009","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ajcp\/aqaa107","article-title":"Diagnosis and treatment of patients with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC)","volume":"154","author":"Arber","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2022.08.010_bib0010","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ajh.23772","article-title":"Characteristics of acute myeloid leukemia with myelodysplasia-related changes: a retrospective analysis in a cohort of Chinese patients","volume":"89","author":"Xu","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2022.08.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106757","article-title":"The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: a retrospective analysis of the FAB subtype RAEB-T","volume":"112","author":"Kaivers","year":"2022","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2022.08.010_bib0012","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ajh.25769","article-title":"Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy","volume":"95","author":"Montalban-Bravo","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2022.08.010_bib0013","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood-2010-04-279794","volume":"116","author":"Miesner","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.clml.2022.08.010_bib0014","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.humpath.2020.08.003","article-title":"Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcome","volume":"104","author":"Jiang","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clml.2022.08.010_bib0015","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00277-014-2100-6","article-title":"Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1","volume":"93","author":"Rozman","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2022.08.010_bib0016","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2008-10-182782","article-title":"Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system","volume":"113","author":"Weinberg","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.08.010_bib0017","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","article-title":"CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia","volume":"36","author":"Lancet","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2022.08.010_bib0018","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41408-021-00558-5","article-title":"Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia","volume":"11","author":"Rautenberg","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2022.08.010_bib0019","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","article-title":"German-Austrian AMLSG. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML","volume":"117","author":"Kayser","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.08.010_bib0020","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.clml.2021.09.019","article-title":"Secondary acute myeloid leukemia (sAML): Similarly dismal outcomes of AML after an antecedent hematologic disorder and therapy related AML","volume":"22","author":"Lalayanni","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2022.08.010_bib0021","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/ajh.25975","article-title":"Acute myeloid leukemia: 2021 update on risk-stratification and management","volume":"95","author":"Estey","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2022.08.010_bib0022","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrclinonc.2012.150","article-title":"The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach","volume":"9","author":"Cornelissen","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clml.2022.08.010_bib0023","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3324\/haematol.2011.040592","article-title":"Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD","volume":"96","author":"de Jonge","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2022.08.010_bib0024","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ajh.24737","article-title":"Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT","volume":"92","author":"Canaani","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2022.08.010_bib0025","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/bmt.2015.59","article-title":"Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission","volume":"50","author":"Michelis","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2022.08.010_bib0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41408-020-0296-3","article-title":"Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia","volume":"10","author":"Schmaelter","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2022.08.010_bib0027","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/10428194.2015.1063148","article-title":"Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes","volume":"57","author":"Ikegawa","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2022.08.010_bib0028","first-page":"1","article-title":"Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel","author":"D\u00f6hner","year":"2022","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265022002713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265022002713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:40:08Z","timestamp":1761871208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265022002713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2152265022002713"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2022.08.010","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2022.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}